Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Newly appointed CMO sees potential in Stayble Therapeutics

Stayble Therapeutics

The Gothenburg-based pharmaceutical company Stayble Therapeutics recently announced Jarkko Kalliomäki as Chief Medical Officer of the company. He is an experienced pain physician and will contribute valuable expertise to the clinical development of the STA363 injection treatment, as well as in future partnership discussions. BioStock interviewed Jarkko Kalliomäki about his new role.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/04/newly-appointed-cmo-sees-potential-in-stayble-therapeutics/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.